Atlas Trials

Mitoxantrone and Clofarabine for Treatment of Recurrent NHL or Acute Leukemia

Clinical trial NCT01842672 · COMPLETED

Trial details

NCT number
NCT01842672
Sponsor
New York Medical College
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Acute Lymphoblastic LeukemiaAcute Myelogenous LeukemiaLymphoblastic LymphomaDiffuse Large B-cell LymphomaBurkitt Lymphoma/Leukemia
Start date
2013-03-01
Primary completion
2021-08-01
Enrollment
41

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.